您的位置: 首页 > 农业专利 > 详情页

INHIBITION DU FACTEUR B ET DE LA VOIE DU COMPLEMENT ALTERNATIVE ET PROCEDES ASSOCIES
专利权人:
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE;NATIONAL JEWISH MEDICAL AND RESEARCH CENTER;MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
发明人:
申请号:
EP05722948.6
公开号:
EP1713503B1
申请日:
2005.02.10
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充